Deferasirox Dispersible Tablets
Product Details:
- Indication Chronic iron overload in patients receiving long-term blood transfusions
- Packaging Type Box
- Brand Name Deferasirox (various brands available depending on region/manufacturer)
- Dosage Form Dispersible Tablet
- Life Span 24 to 36 months from the date of manufacture
- Salt Composition Deferasirox
- Origin of Medicine India
- Click to View more
X
Deferasirox Dispersible Tablets Price And Quantity
- 5 Bottle
- Hematological agents (Iron Chelating Agent)
- White to off-white
- Blister packing in cardboard box
- Disperses in water within 3 minutes
- May include nausea, vomiting, abdominal pain, skin rash, elevated serum creatinine
- Prescription only (Rx)
- Oral
- Available in strengths of 100 mg, 250 mg, and 500 mg
- V03AC03
- Approved by regulatory authorities such as CDSCO/USFDA for specified indications
- Severe renal or hepatic impairment, hypersensitivity to Deferasirox
- India
- Do not discontinue or modify dose without consulting healthcare provider
- Multiple Indian pharmaceutical companies
- Not recommended during pregnancy and lactation without physician supervision
Deferasirox Dispersible Tablets Product Specifications
- As directed by Physician
- Dispersible Tablet
- Deferasirox
- 24 to 36 months from the date of manufacture
- Treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients with beta-thalassemia major and other chronic anemias
- Deferasirox (various brands available depending on region/manufacturer)
- As directed by physician, typically once daily
- Deferasirox
- 6, 12, 30 Tablets (varies by manufacturer)
- India
- Variable (commonly available in 6, 12, or 30 tablets per box)
- Tablets
- Adults, Children
- Iron chelation therapy - removes excess iron from the body
- Chronic iron overload in patients receiving long-term blood transfusions
- Box
- Cool and Dry Place
- Other Types
- Hematological agents (Iron Chelating Agent)
- White to off-white
- Blister packing in cardboard box
- Disperses in water within 3 minutes
- May include nausea, vomiting, abdominal pain, skin rash, elevated serum creatinine
- Prescription only (Rx)
- Oral
- Available in strengths of 100 mg, 250 mg, and 500 mg
- V03AC03
- Approved by regulatory authorities such as CDSCO/USFDA for specified indications
- Severe renal or hepatic impairment, hypersensitivity to Deferasirox
- India
- Do not discontinue or modify dose without consulting healthcare provider
- Multiple Indian pharmaceutical companies
- Not recommended during pregnancy and lactation without physician supervision
Deferasirox Dispersible Tablets Trade Information
- Mumbai
- 500 Bottle Per Week
- 15 Days
- As Per Requirement.
- Western Europe, Australia, Eastern Europe, Middle East, Africa, Central America, South America, Asia, North America
- All India
Product Description
Experience the glorious prime of Iron Chelation Therapy with Deferasirox Dispersible Tablets-your top-ranking solution for chronic iron overload due to blood transfusions. Available in sizzling strengths of 100 mg, 250 mg, and 500 mg, these white to off-white tablets disperse ephemerally in water within 3 minutes, ensuring swift preparation. Ending soon-stock is variable, so secure your prescription. Each tablet is rigorously approved and blister packaged for safety, sourced from market-leading Indian exporters and suppliers, for an unmatched standard in patient care.
Targeted Use: Who and How to Administer
Deferasirox Dispersible Tablets are meticulously used by patients with chronic iron overload, especially those with transfusional hemosiderosis in beta-thalassemia major or other chronic anemias. Suitable for both adults and children, it is administered orally once daily, precisely as directed by a healthcare provider. The tablets are designed to disperse entirely in water before intake, ensuring optimal absorption and therapeutic efficacy through this application medium.
Unmatched Supply Capacity and Delivery Logistics
With robust supply ability and expeditious logistics, Deferasirox Dispersible Tablets guarantee prompt arrival post-purchase order confirmation. Delivery times are streamlined and reliable, reflecting adherence to high-quality export standards from India. Each shipment is accompanied by requisite certification from CDSCO or USFDA, assuring top-quality compliance. Whether the requirement is for clinic, hospital, or pharmacy, orders are efficiently fulfilled with packaging in variable quantities for diverse needs.
Targeted Use: Who and How to Administer
Deferasirox Dispersible Tablets are meticulously used by patients with chronic iron overload, especially those with transfusional hemosiderosis in beta-thalassemia major or other chronic anemias. Suitable for both adults and children, it is administered orally once daily, precisely as directed by a healthcare provider. The tablets are designed to disperse entirely in water before intake, ensuring optimal absorption and therapeutic efficacy through this application medium.
Unmatched Supply Capacity and Delivery Logistics
With robust supply ability and expeditious logistics, Deferasirox Dispersible Tablets guarantee prompt arrival post-purchase order confirmation. Delivery times are streamlined and reliable, reflecting adherence to high-quality export standards from India. Each shipment is accompanied by requisite certification from CDSCO or USFDA, assuring top-quality compliance. Whether the requirement is for clinic, hospital, or pharmacy, orders are efficiently fulfilled with packaging in variable quantities for diverse needs.
FAQ's of Deferasirox Dispersible Tablets:
Q: How should Deferasirox Dispersible Tablets be administered?
A: Deferasirox tablets must be dispersed fully in water, then consumed orally, typically once a day as prescribed by your healthcare provider. Do not chew or swallow them whole.Q: What are the primary uses of Deferasirox Dispersible Tablets?
A: These tablets are primarily indicated for managing chronic iron overload in patients who undergo regular blood transfusions, such as those with beta-thalassemia major and other chronic anemias.Q: When should Deferasirox not be used?
A: Deferasirox should not be used in patients with severe renal or hepatic impairment or in individuals who are hypersensitive to the drug. Consult your doctor if you have any known contraindications.Q: Where do Deferasirox Dispersible Tablets originate from?
A: These tablets are manufactured and exported mainly from India, supplied by top-ranking pharmaceutical companies with approvals from regulatory authorities like CDSCO and USFDA.Q: What precautions should patients take during therapy?
A: Patients should strictly follow physician instructions and avoid discontinuation or dosage modification without consulting their healthcare provider. Regular monitoring of kidney function is recommended during therapy.Q: How are the tablets packaged and stored?
A: Each batch is blister-packed and supplied in cardboard boxes, available in pack sizes of 6, 12, or 30 tablets. They must be stored in a cool, dry place away from direct sunlight for optimal shelf life.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Pharmaceutical Tablet' category
SPARK LIFESCIENCES
GST : 24ACKFS9546B1ZZ
Contact Details
- B No. 220, Samanvay Silicon, Beside Datta Mandir, Opposite Kalyan Cafe, Sayajigunj,Vadodara - 390020, Gujarat, India
- Phone :08045475752
- Mr Gaurang Patel (Partner)
- Mobile :08045475752
Send Inquiry
Send SMSSPARK LIFESCIENCES
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
